IRIS PubliCatt

Dragonetti, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 440
EU - Europa 264
AS - Asia 36
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 748
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 438
SE - Svezia 104
IT - Italia 46
IE - Irlanda 40
CN - Cina 22
DE - Germania 22
FR - Francia 22
FI - Finlandia 5
RU - Federazione Russa 5
ES - Italia 4
IN - India 4
CH - Svizzera 3
GB - Regno Unito 3
BE - Belgio 2
BR - Brasile 2
CZ - Repubblica Ceca 2
EU - Europa 2
HK - Hong Kong 2
IL - Israele 2
TW - Taiwan 2
UA - Ucraina 2
AU - Australia 1
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
CL - Cile 1
JP - Giappone 1
MX - Messico 1
MY - Malesia 1
NL - Olanda 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SG - Singapore 1
TR - Turchia 1
Totale 748
Salva come PNG Salva come JPEG
Città #
Chandler 134
Ashburn 75
Dublin 40
Marseille 19
Beijing 16
New York 15
Bremen 14
Princeton 14
Boston 13
San Mateo 13
Washington 13
Milan 12
Chicago 7
Rome 7
Wilmington 7
Ann Arbor 4
Falls Church 4
Busto Arsizio 3
Dearborn 3
Lappeenranta 3
London 3
Nanjing 3
Valladolid 3
Augusta 2
Bern 2
Brno 2
Brussels 2
Como 2
Helsinki 2
Hong Kong 2
Paris 2
Parma 2
Perugia 2
Pune 2
São Paulo 2
Abidjan 1
Alameda 1
Andover 1
Boardman 1
Cambridge 1
Cattolica 1
Cavalese 1
Esslingen am Neckar 1
Fairfield 1
Falkenstein 1
Florence 1
Frankfurt am Main 1
Groningen 1
Gunzenhausen 1
Hebei 1
Izmir 1
Jiaxing 1
Kaohsiung 1
Kuala Lumpur 1
Latiano 1
Leawood 1
Logan 1
Madrid 1
Mexico City 1
Moldova Noua 1
Montreal 1
Mumbai 1
Nanchang 1
Niš 1
Novokuznetsk 1
Redmond 1
Redwood City 1
Seattle 1
Sofia 1
Taipei 1
Tivoli 1
Zurich 1
Totale 486
Salva come PNG Salva come JPEG
Nome #
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 76
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 60
'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study 57
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA 45
Rhodotorula infection in haematological patient: Risk factors and outcome 44
Developments in identifying and managing mucormycosis in hematologic cancer patients 44
Rhodotorula infection in haematological patient: Risk factors and outcome 43
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 42
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 42
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 41
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 41
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study) 39
Pharyngeal microbial signatures are predictive of the risk of fungal pneumonia in hematologic patients 35
Disseminated geosmithia argillacea infection in a patient with ph-positive acute lymphoblastic leukemia. Case report and literature review 33
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry 21
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) 20
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 17
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax 15
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey 15
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry 11
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry 11
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report 10
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey 9
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey 4
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings 2
SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report 2
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 2
Totale 781
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.412
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202024 6 1 2 0 0 0 4 6 2 3 0 0
2020/202117 0 0 3 4 1 0 4 0 0 0 5 0
2021/2022117 2 0 2 7 6 6 1 14 16 9 20 34
2022/2023384 45 43 24 61 32 44 27 31 44 9 18 6
2023/2024231 12 56 25 19 12 67 30 1 5 4 0 0
Totale 781